AGT Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Cash GenerationAptar reports strong cash generation (TTM operating cash flow and rising free cash flow), with a recent quarter showing FCF more than doubled. Durable cash conversion provides funding for capex, R&D, dividends and buybacks, supporting reinvestment and capital returns over the medium term.
Pharma Pipeline And Regulatory WinsRegulatory approvals and an advancing pharma pipeline validate Aptar’s drug-delivery platforms. Successful label expansions and generic-device wins deepen customer adoption, create high barriers to entry via qualification cycles, and underpin durable, higher-margin recurring revenue from pharmaceutical customers.
Designed-in Customer Relationships And Proprietary TechAptar’s unit-volume model relies on long qualification cycles and proprietary dispensing technologies, creating switching costs and recurring orders. Global manufacturing scale and engineered product differentiation support multi-year contracts and steady demand across Beauty, Closures and Pharma segments.
Bears Say
TTM Balance-sheet Anomaly (very Low Equity)An extremely low TTM equity base and resultant very high debt-to-equity materially weaken financial resilience. This reduces the company’s capacity to absorb shocks, raises refinancing and covenant risk, and constrains strategic optionality like M&A or large share repurchases if deleveraging is not achieved.
Sharp Gross-margin DeteriorationA large decline in gross margin versus prior years signals meaningful cost, mix, or pricing pressure. If persistent, this undermines operating leverage and sustainable profitability, forcing either structural price increases, cost-cutting, or capital investment to restore prior margin levels over the medium term.
Operational Disruptions And Destocking HeadwindEmergency-medicine destocking, supplier fires, weather-related plant closures and rising input costs create durable operational volatility. Such disruptions and pass-through timing gaps can depress core sales and compress margins across quarters, complicating predictable sales growth and margin recovery.
AptarGroup News
AGT FAQ
What was AptarGroup, Inc.’s price range in the past 12 months?
Currently, no data Available
What is AptarGroup, Inc.’s market cap?
AptarGroup, Inc.’s market cap is CHF6.74B.
When is AptarGroup, Inc.’s upcoming earnings report date?
AptarGroup, Inc.’s upcoming earnings report date is Jul 30, 2026 which is in 8 days.
How were AptarGroup, Inc.’s earnings last quarter?
AptarGroup, Inc. released its earnings results on Apr 30, 2026. The company reported $0.968 earnings per share for the quarter, beating the consensus estimate of $0.935 by $0.033.
Is AptarGroup, Inc. overvalued?
According to Wall Street analysts AptarGroup, Inc.’s price is currently Undervalued.
Does AptarGroup, Inc. pay dividends?
AptarGroup, Inc. does not currently pay dividends.
What is AptarGroup, Inc.’s EPS estimate?
AptarGroup, Inc.’s EPS estimate is 1.1.
How many shares outstanding does AptarGroup, Inc. have?
Currently, no data Available
What happened to AptarGroup, Inc.’s price movement after its last earnings report?
AptarGroup, Inc. reported an EPS of $0.968 in its last earnings report, beating expectations of $0.935. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of AptarGroup, Inc.?
Currently, no hedge funds are holding shares in CH:AGT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AptarGroup Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF120.59 (― Downside)
CHF120.59 (― Downside)
Insider Transactions
Sold Shares
Worth CHF1.3M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.73%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
12.61%
Trailing 12-Months
Company Description
AptarGroup, Inc.
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
AGT Stock 12 Month Forecast
Average Price Target
$120.59
Baxter International
―
Cooper Co
―
Repligen
―
West Pharmaceutical Services
―
Stevanato Group
―